These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32484873)

  • 21. Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
    Olawuyi O; Mathieson K
    Curr Drug Saf; 2020; 15(3):173-180. PubMed ID: 32525783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.
    Heffner JL; Evins AE; Russ C; Lawrence D; Ayers CR; McRae T; Aubin LS; Krishen A; West R; Anthenelli RM
    J Affect Disord; 2019 Sep; 256():267-277. PubMed ID: 31195244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    Benowitz NL; Pipe A; West R; Hays JT; Tonstad S; McRae T; Lawrence D; St Aubin L; Anthenelli RM
    JAMA Intern Med; 2018 May; 178(5):622-631. PubMed ID: 29630702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study.
    Tran DT; Preen DB; Einarsdottir K; Kemp-Casey A; Randall D; Jorm LR; Choi SKY; Havard A
    BMC Med; 2020 Feb; 18(1):15. PubMed ID: 32019533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
    Stead LF; Koilpillai P; Lancaster T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009670. PubMed ID: 26457723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
    Gobarani RK; Ilomäki J; Wood S; Abramson MJ; Bonevski B; George J
    Addiction; 2022 Oct; 117(10):2683-2694. PubMed ID: 35603915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009670. PubMed ID: 23235680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological interventions for promoting smoking cessation during pregnancy.
    Coleman T; Chamberlain C; Davey MA; Cooper SE; Leonardi-Bee J
    Cochrane Database Syst Rev; 2012 Sep; (9):CD010078. PubMed ID: 22972148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking Cessation Pharmacotherapy Use in Pregnancy.
    Robijn AL; Tran DT; Cohen JM; Donald S; Cesta CE; Furu K; Parkin L; Pearson SA; Reutfors J; Zoega H; Zwar N; Havard A
    JAMA Netw Open; 2024 Jun; 7(6):e2419245. PubMed ID: 38941092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of varenicline and nicotine replacement therapy in people with and without general practitioner-recorded dementia: retrospective cohort study of routine electronic medical records.
    Itani T; Martin R; Rai D; Jones T; Taylor G; Thomas K; Munafo M; Davies N; Taylor A
    BMJ Open; 2019 Aug; 9(8):e027569. PubMed ID: 31473613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
    Suissa K; Larivière J; Eisenberg MJ; Eberg M; Gore GC; Grad R; Joseph L; Reynier PM; Filion KB
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28093398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.
    Peckham E; Brabyn S; Cook L; Tew G; Gilbody S
    BMC Psychiatry; 2017 Jul; 17(1):252. PubMed ID: 28705244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-care providers' concern regarding smoking cessation pharmacotherapies during pregnancy: Calls to a teratology information service.
    Lee ML; Tran DT; Welsh A; Kennedy D; Havard A
    Drug Alcohol Rev; 2020 Mar; 39(3):223-231. PubMed ID: 31984591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis.
    Smith PH; Weinberger AH; Zhang J; Emme E; Mazure CM; McKee SA
    Nicotine Tob Res; 2017 Mar; 19(3):273-281. PubMed ID: 27613893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan.
    Chang PY; Lo PC; Chang HC; Hsueh KC; Tsai YW
    PLoS One; 2016; 11(11):e0166992. PubMed ID: 27893843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Caldwell D; Dalili MN; Gunnell D; Munafò MR; Stevenson M; Welton NJ
    BMJ Open; 2017 Jun; 7(6):e015414. PubMed ID: 28624760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo DM; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Addiction; 2022 Apr; 117(4):861-876. PubMed ID: 34636108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.
    Keeney E; Welton NJ; Stevenson M; Dalili MN; López-López JA; Caldwell DM; Phillippo DM; Munafò MR; Thomas KH
    Value Health; 2021 Jun; 24(6):780-788. PubMed ID: 34119075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular and Neuropsychiatric Events after Varenicline Use for Smoking Cessation.
    Gershon AS; Campitelli MA; Hawken S; Victor C; Sproule BA; Kurdyak P; Selby P
    Am J Respir Crit Care Med; 2018 Apr; 197(7):913-922. PubMed ID: 29260881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.